Greg H Gardella is a partner in Oblon Spivak McClelland Maier & Neustadt LLP’s post-grant patent practice group, focusing on post-grant patent proceedings, patent prosecution, strategic counselling, due diligence investigations and pre-suit investigations. Mr Gardella is a former litigator, having spent the first several years of his practice handling high-stakes patent litigation for various Fortune 100 clients. He leverages his extensive litigation background to focus on adversarial post-grant US Patent and Trademark Office (USPTO) proceedings. A distinguished re-examination specialist, he has handled a significant number of high-stakes patent reexamination disputes, such as the defence of the famous TiVo time warp patent and serving as lead counsel for St Jude Medical in its post-grant challenges of Medtronic’s renal denervation portfolio.
Prior to joining Oblon Spivak, Mr Gardella was a partner at Irell & Manella, LLP. While there, he chaired the re-examination practice group and oversaw the training of lawyers and patent agents related to USPTO proceedings.
Mr Gardella also develops and manages the patent portfolios of mid-sized and large technology-focused companies. He has extensive experience in strategic enforcement and freedom to operate counselling, where he advises companies on how best to enforce their patent portfolios and take defensive measures to circumvent patent assertions by competitors.
Mr Gardella has substantial education and experience in the following technical areas: semiconductor fabrication and device structure, computer architecture, wireless telecommunications, network data communication, software ranging from microcode to application layer, medical devices, signal processing, embedded controllers, VLSI design, microstructured films and various types of industrial equipment.